Log In
Print this Print this

Hemofil M

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionAntihemophilic factor (AHF)
Molecular Target Factor VIII
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationHemophilia
Indication DetailsPrevent and control hemorrhagic episodes in patients with hemophilia A
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today